Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

标题
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
作者
关键词
-
出版物
LANCET ONCOLOGY
Volume 13, Issue 9, Pages 879-886
出版商
Elsevier BV
发表日期
2012-08-13
DOI
10.1016/s1470-2045(12)70324-8

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation